CompaniesInvestorsPeople
Home
Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

  • Contact

  • Request a Demo

  • Request Data Updates

  • Add a Company

Research

  • Companies

  • Investors

  • People

aVenture

  • Download App

  • Pricing

Download the aVenture Research beta for iOS and iPadOSDownload aVenture Research on the Mac App Store

Resources

  • Documentation

  • Use Cases

  • CLI

  • MCP

  • Feature Requests

  • Sitemap

Member

Backed by

Ask AI about aVenture

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy · Terms of Service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading
Home›
Companies›
Petra Pharma›
Fundraising
Petra Pharma logo

Petra Pharma

Operating Status: Inactive

Petra Pharma, a NY-based company, develops novel therapies for serious conditions like cancer and metabolic diseases.

New York City, NY, US🇺🇸
Founded
2016
Loading
Overview
Compare
Fundraising
Employees

Petra Pharma - Funding History

Round

Date

Amount Raised

Raised To-Date

Investors

Debt
April 2020
$27,545,484
$75,545,484
0
Series A
January 2016
$48,000,000
$48,000,000
13

Petra Pharma - Investors

Petra Pharma has raised money from at least 13 different investors as of October 16, 2026

Name

Location

Links

Type

Employees

Round(s)

Partnership for New York CityPartnership for New York City
New York City, NY, US
LinkedIn
Fund
-
Series A
Accelerator Life Science PartnersAccelerator Life Science Partners
Seattle, WA, US
Company
17
Series A
Pfizer Venture InvestmentsPfizer Venture Investments
New York City, NY, US
Investment Firm
30
Series A
Empire State DevelopmentEmpire State Development
New York City, NY, US
LinkedIn
Government Agency
750
Series A
AlexandriaAlexandria
Pasadena, CA, US
-
Investment Firm
593
Series A
Watson FundWatson Fund
Seattle, WA, US
Investment Firm
50
Series A
Harris & Harris GroupHarris & Harris Group
New York City, NY, US
Investment Firm
5
Series A
Johnson & Johnson Robotics and Digital SolutionsJohnson & Johnson Robotics and Digital Solutions
New Brunswick, NJ, US
-
Company
33
Series A
Eli Lilly and CompanyEli Lilly and Company
-
LinkedIn
Company
39,000
Series A
Arch Venture PartnersArch Venture Partners
Chicago, IL, US
LinkedIn
Investment Firm
67
Series A